Tirzepatide
A dual GIP/GLP-1 receptor agonist offering strong appetite suppression and glucose…
The read
What people observed
Every report answers on a 1–5 scale. This is the whole distribution, never an average pretending to be one number, though the average is beside it.
1 · no effect
6
2 · barely
5
3 · modest
3
4 · clearly worked
9
5 · textbook
4
3.0/5
Average reported outcome
78%
Would run it again
27
Reports filed · directional
What it did, and what else showed up
Counts across this compound's reports, never an average. One report can select several answers.
Reported positive outcomes
joint / tendon relief
8
injury healing
6
skin / hair
5
mood / focus
5
fat loss
4
better sleep
3
cognition
3
cardiovascular / circulation
3
faster recovery
2
libido
2
strength / pump
2
better bloodwork
2
more energy
1
Reported side effects
Kept separate from positive outcomes on purpose.
headache
6
sleep disruption
5
none / clean
4
fatigue
4
GI / nausea
4
mood / anxiety
4
injection-site irritation
3
appetite change
3
heart rate
2
How it was run
What people brought it in for, and how long they stayed on it. Intent, not a result or a treatment claim.
What people were researching
skin / hair
3
body composition
2
cardiovascular / blood pressure
2
longevity / healthspan
2
appetite / weight
1
energy / endurance
1
recovery / injury
1
sleep
1
mood / anxiety
1
libido / sexual function
1
How long they ran it
1 wk
4
2 wk
5
4 wk
1
6 wk
4
8 wk
4
12 wk
6
16 wk+
3
Anecdote, never medical advice.
These are anonymous personal reports on an experimental research compound, not clinical evidence, and they never set the grade. Talk to a licensed clinician before you start, stop, or change a dose.